Work

Pain and Functional Outcomes After a Single Intra-Articular Hyaluronic Acid Injection in Grade II and III Knee Osteoarthritis

Year: 2026
Type: article
Abstract: Background: The incremental benefit of intra-articular hyaluronic acid remains uncertain. This study assessed six-month pain and functional outcomes after a single injection for knee osteoarthritis.Materials and Methods. This prospective observational study included 30 patients with Kellgren–Lawrence grade II or III knee osteoarthritis during January 2023–September 2025. Each patient received a single intra-articular injection of 48 mg hyaluronic acid in 6 mL. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) totals were assessed at baseline, six weeks, three months, and six months; visual analog scale (VAS) pain scores (0–10) were available at baseline and six months. Analyses used paired t-tests with Holm adjustment and pointwise confidence intervals.Results. Mean age was 60.97 ± 9.81 years; 17 patients (56.7%) were male. Mean body mass index was 26.40 ± 2.78 kg/m². All 30 patients had complete observations; no outcome values were imputed. Mean WOMAC totals decreased from 67.33 ± 3.84 at baseline to 58.67 ± 3.50 at six weeks, 52.27 ± 2.66 at three months, and 44.67 ± 2.48 at six months. Mean reductions were 8.67 points (95% confidence interval [CI] 7.70–9.63), 15.07 points (13.96–16.17), and 22.67 points (21.47–23.86), respectively. Mean VAS scores decreased from 7.40 ± 0.93 to 3.37 ± 1.33; the paired reduction was 4.03 points (95% CI 3.62–4.44). Six-month reductions represented 33.7% and 54.5% of baseline group means, respectively. All four comparisons and exact sign tests had Holm-adjusted p < 0.001. Every patient improved on each analyzed outcome. No major complications or infections were reported; minor reactions were not systematically quantified.Conclusions. Pain and recorded WOMAC total scores improved over six months following a single hyaluronic acid injection. Controlled studies are required to establish treatment-specific benefit; uncertain WOMAC scoring limits interpretation.
Language: English
Subfield: Rheumatology
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7234389936
FWCI:
Cites: 21
Cited by:
Related to: 10